PFCS
DERM icon

Pale Fire Capital SE’s Journey Medical DERM Stock Holding History

Pale Fire Capital SE’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Buy
528,584
+46,597
+10% +$266K 0.26% 29
2026
Q1 		$2.26M Buy
481,987
+37,345
+8% +$290K 0.2% 25
2025
Q4 		$3.43M Buy
444,642
+216,075
+95% +$1.69M 0.23% 25
2025
Q3 		$1.63M Buy
228,567
+196,109
+604% +$1.42M 0.18% 26
2025
Q2 		$233K Buy
32,458
+5,184
+19% +$35.8K 0.02% 40
2025
Q1 		$161K Buy
+27,274
New +$134K 0.02% 42

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pale Fire Capital SE's DERM Position: Q2 2026 in Review

Pale Fire Capital SE increased its Journey Medical (DERM) stake by 9.7% in Q2 2026, buying an estimated $266K and bringing the position to 528,584 shares worth $3.74M. The position accounts for 0.26% of the portfolio, ranked #29.

Pale Fire Capital SE first reported a position in DERM in Q1 2025 and has held it in 6 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Pale Fire Capital SE held 528,584 shares of Journey Medical worth $3.74M as of Q2 2026.
  • Pale Fire Capital SE bought 46,597 Journey Medical shares in Q2 2026, an estimated $266K.
  • Journey Medical made up 0.26% of Pale Fire Capital SE's portfolio in Q2 2026, its #29 holding.
  • Pale Fire Capital SE first reported a position in Journey Medical in Q1 2025 and has held it in 6 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.